Weiss RH - Search Results

1

Targeting the PI3K-Akt pathway in kidney cancer.

Park JY, Lin PY, Weiss RH. Park JY, et al. Among authors: weiss rh. Expert Rev Anticancer Ther. 2007 Jun;7(6):863-70. doi: 10.1586/14737140.7.6.863. Expert Rev Anticancer Ther. 2007. PMID: 17555396 Review.

2

Pathway analysis of kidney cancer using proteomics and metabolic profiling.

Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH. Perroud B, et al. Among authors: weiss rh. Mol Cancer. 2006 Nov 24;5:64. doi: 10.1186/1476-4598-5-64. Mol Cancer. 2006. PMID: 17123452 Free PMC article.

3

Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.

Lin PY, Fosmire SP, Park SH, Park JY, Baksh S, Modiano JF, Weiss RH. Lin PY, et al. Among authors: weiss rh. Mol Cancer. 2007 Feb 14;6:16. doi: 10.1186/1476-4598-6-16. Mol Cancer. 2007. PMID: 17300726 Free PMC article.

4

Antisense attenuation of p21 sensitizes kidney cancer to apoptosis in response to conventional DNA damaging chemotherapy associated with enhancement of phospho-p53.

Park SH, Park JY, Weiss RH. Park SH, et al. Among authors: weiss rh. J Urol. 2008 Jul;180(1):352-60. doi: 10.1016/j.juro.2008.02.038. Epub 2008 May 21. J Urol. 2008. PMID: 18499163 Free PMC article.

5

p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches.

Weiss RH, Borowsky AD, Seligson D, Lin PY, Dillard-Telm L, Belldegrun AS, Figlin RA, Pantuck AD. Weiss RH, et al. J Urol. 2007 Jan;177(1):63-8; discussion 68-9. doi: 10.1016/j.juro.2006.08.073. J Urol. 2007. PMID: 17162001

6

p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels.

Park JY, Schutzer WE, Lindsley JN, Bagby SP, Oyama TT, Anderson S, Weiss RH. Park JY, et al. Among authors: weiss rh. BMC Nephrol. 2007 Aug 22;8:12. doi: 10.1186/1471-2369-8-12. BMC Nephrol. 2007. PMID: 17714589 Free PMC article.

7

Disparate effects of roscovitine on renal tubular epithelial cell apoptosis and senescence: implications for autosomal dominant polycystic kidney disease.

Park JY, Park SH, Weiss RH. Park JY, et al. Among authors: weiss rh. Am J Nephrol. 2009;29(6):509-15. doi: 10.1159/000184590. Epub 2008 Dec 10. Am J Nephrol. 2009. PMID: 19066425 Free PMC article.

8

Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy.

Inoue H, Hwang SH, Wecksler AT, Hammock BD, Weiss RH. Inoue H, et al. Among authors: weiss rh. Cancer Biol Ther. 2011 Nov 1;12(9):827-36. doi: 10.4161/cbt.12.9.17680. Epub 2011 Nov 1. Cancer Biol Ther. 2011. PMID: 21878748 Free PMC article.

9

PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.

Abu Aboud O, Donohoe D, Bultman S, Fitch M, Riiff T, Hellerstein M, Weiss RH. Abu Aboud O, et al. Among authors: weiss rh. Am J Physiol Cell Physiol. 2015 Jun 1;308(11):C890-8. doi: 10.1152/ajpcell.00322.2014. Epub 2015 Mar 25. Am J Physiol Cell Physiol. 2015. PMID: 25810260 Free PMC article.

10

Kidney cancer: identification of novel targets for therapy.

Weiss RH, Lin PY. Weiss RH, et al. Kidney Int. 2006 Jan;69(2):224-32. doi: 10.1038/sj.ki.5000065. Kidney Int. 2006. PMID: 16408110 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters